Abu Dhabi:H.H. Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, chaired a meeting of the Emirates Genome Council where he approved the 2026-2031 National Genomics Masterplan. This plan outlines the next phase of clinical initiatives under the UAE's National Genome Strategy, focusing on implementing genomic data in advanced health, early prevention, and personalized medicine.
According to Wam, the meeting took place as part of the UAE Government Annual Meetings. H.H. Sheikh Khaled reviewed the latest updates of the Emirati Genome Program, which has reached a milestone of one million participants, marking it as the world's most comprehensive population genome program. He emphasized the importance of expanding preventative care programs and translating research findings into practical applications to enhance community health and quality of life.
The meeting was attended by several high-profile officials, including Mohammad Al Gergawi, Minister of Cabinet Affairs, and Ahmed Ali Al Sayegh, Minister of Health and Prevention. Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health - Abu Dhabi and Secretary-General of the Emirates Genome Council, highlighted that the 2026-2031 National Genomics Masterplan sets new criteria for implementing genomics in clinical applications. The plan aims to extend access to the Emirati Genome Program to all Emirati citizens, provide personalized genomic reports, expand the Newborn Genetic Screening Programme, and strengthen the Trusted Research Environment.
Personalized genomic reports available through the TAMM platform from December 2026 will include information about 214 inherited genomic conditions and health traits. The Newborn Genetic Screening Programme will cover more than 730 genes linked to over 815 childhood genetic conditions. The Trusted Research Environment supports AI in data analysis and the development of precision medicine applications. The National Genomics Masterplan reflects the UAE's vision for a proactive healthcare ecosystem powered by data and AI to promote longevity and quality of life.